What is the appropriate lisinopril dosing for adults with hypertension, heart failure, post‑myocardial infarction, and diabetic nephropathy, and how should the dose be adjusted for impaired renal function, elderly patients, and pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Dosing

Start lisinopril at 2.5-5 mg once daily and titrate upward by doubling the dose every 2 weeks to reach target doses of 20-40 mg daily for hypertension and heart failure, with mandatory monitoring of renal function and potassium within 1-2 weeks after each dose change. 1, 2, 3

Starting Doses by Indication

Heart Failure with Reduced Ejection Fraction

  • Begin at 2.5-5 mg once daily, using the lower 2.5 mg dose in patients who are volume-depleted or on concurrent diuretics 1, 3
  • Target dose is 20-40 mg once daily, with evidence showing that higher doses (32.5-35 mg daily) reduce death or hospitalization by 12% and heart failure hospitalizations by 24% compared to low doses 3, 4
  • Aim for at least 50% of target dose (10 mg daily) if the full target cannot be tolerated, as some ACE inhibitor is better than none 1, 3

Hypertension

  • Start at 10 mg once daily for most patients with essential hypertension 5
  • Usual maintenance range is 20-40 mg once daily, though doses up to 80 mg have been used 6, 7

Post-Myocardial Infarction

  • Initiate at 5 mg within 24 hours of symptom onset, then 5 mg after 24 hours, 10 mg after 48 hours, and target 10 mg daily thereafter 6

Diabetic Nephropathy

  • Use standard hypertension dosing (10-20 mg daily) with close monitoring of renal function and proteinuria 8

Titration Protocol

Dose Escalation Schedule

  • Double the dose at intervals of not less than 2 weeks if the previous dose was well tolerated 1, 2, 3
  • Monitor blood pressure, serum creatinine, and potassium within 1-2 weeks after initiation and after each dose increase 1, 2
  • Continue monitoring at 3 months, then every 6 months during maintenance therapy 3

When to Stop Up-Titration

  • An increase in creatinine up to 50% above baseline or up to 3 mg/dL (whichever is greater) is acceptable and expected—do not stop lisinopril for this 2, 3
  • If creatinine rises to 3.0-3.5 mg/dL, halve the lisinopril dose and monitor blood chemistry closely 2
  • If creatinine exceeds 3.5 mg/dL, stop lisinopril immediately and monitor blood chemistry closely 2

Renal Dose Adjustments

Initiation Thresholds Based on Creatinine

  • Creatinine ≤2.5 mg/dL: Initiate at standard doses without significant concern 2
  • Creatinine 2.5-3.0 mg/dL: Use with caution and close monitoring 2
  • Creatinine >3.0 mg/dL: Avoid or use with extreme caution, seek specialist advice 2

Dose Adjustments for Impaired Renal Function

  • For creatinine clearance 10-30 mL/min, reduce initial dose to 2.5 mg once daily 6, 5
  • For creatinine clearance <10 mL/min, reduce initial dose to 2.5 mg and use with extreme caution 5
  • Elderly patients often require lower dosages due to age-related reductions in renal function 6, 5

Critical Monitoring Requirements

Before Initiation

  • Check serum creatinine, potassium, and blood pressure before starting lisinopril 1, 2
  • Discontinue NSAIDs immediately, as they worsen renal function and cause diuretic resistance 2, 9
  • Stop potassium supplements and potassium-sparing diuretics due to hyperkalemia risk 2

During Titration

  • Recheck creatinine and potassium 1-2 weeks after each dose change 1, 2
  • Monitor for symptomatic hypotension, though asymptomatic low blood pressure does not require dose reduction 1, 2

High-Risk Populations Requiring Extra Caution

  • Patients with pre-existing hypotension (systolic BP <90 mmHg), diabetes, volume depletion, or bilateral renal artery stenosis are at increased risk of creatinine rise 1, 2

Managing Common Adverse Effects

Hyperkalemia

  • For potassium 5.5-5.9 mmol/L: Stop potassium supplements, reduce diuretics if no congestion present, continue lisinopril at current dose 2
  • For potassium ≥6.0 mmol/L: Stop potassium supplements, seek specialist advice before discontinuing lisinopril 2
  • Consider adding an SGLT2 inhibitor, which reduces serious hyperkalemia risk by 16% and allows continuation of RAAS inhibitors 1

Symptomatic Hypotension

  • Reduce diuretic dose first if no signs or symptoms of congestion are present 1, 2
  • Reconsider need for nitrates, calcium channel blockers, and other vasodilators before reducing lisinopril 1
  • Only reduce lisinopril dose if hypotension persists after these measures 1

Worsening Renal Function

  • Discontinue NSAIDs and non-essential vasodilators immediately 2, 9
  • Halve the lisinopril dose if creatinine rises to 3.0-3.5 mg/dL 2
  • Do not stop lisinopril for minor laboratory changes, as withdrawal is associated with clinical deterioration 1, 2

ACE Inhibitor Cough

  • Cough is common (up to 20% of patients) but rarely requires discontinuation 1, 3
  • If cough is proven to be ACE inhibitor-induced and severely troublesome (e.g., stopping sleep), consider switching to an ARB 1

Critical Pitfalls to Avoid

Do Not Undertitrate

  • Target doses provide superior mortality and morbidity benefits—the ATLAS trial showed high-dose lisinopril (32.5-35 mg daily) reduced death or hospitalization by 12% compared to low doses (2.5-5 mg daily) 3, 4
  • Aim for at least 50% of target dose for optimal clinical benefit 3

Do Not Abruptly Withdraw

  • Abrupt withdrawal of lisinopril leads to clinical deterioration and worse outcomes 1, 2
  • If adverse effects occur, adjust concomitant medications first (diuretics, vasodilators, NSAIDs) before reducing or stopping lisinopril 1, 2

Do Not Stop for Expected Laboratory Changes

  • Up to 50% increase in creatinine is acceptable and does not require discontinuation 2, 3
  • Stopping lisinopril for minor laboratory changes causes more harm than benefit 2, 3

Special Populations

Elderly Patients

  • Use lower starting doses (2.5 mg daily) due to age-related reductions in renal function 6, 5
  • Dosages effective in elderly patients range from 2.5-40 mg daily, with no clinically significant age-related differences in efficacy 6

Pregnancy

  • Lisinopril is absolutely contraindicated in pregnancy (FDA Category D)—discontinue immediately if pregnancy is detected [@general medical knowledge@]

Diabetic Patients

  • Use standard dosing with close monitoring of renal function and proteinuria 8
  • Lisinopril reduces mortality in diabetic patients after myocardial infarction and may improve diabetic nephropathy and neuropathy 6, 8

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.